Latest ALS Stories
$100,000 prize and access to additional expertise awarded to support "big data" genetic analysis to provide new clues to the higher incidence of ALS in veterans BRIDGEWATER, N.J., May 12, 2014
ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc.
Fox Subacute Salutes the Strength of Those Diagnosed with ALS and Their Caregivers and Loved Ones; ALS Patient Care Burdens May Be Lessened with the Aid of a Subacute Facility Plymouth
Papa John's Founder, Chairman and CEO John Schnatter Agrees to Serve as National Walk Ambassador WASHINGTON, May 8, 2014 /PRNewswire-USNewswire/ -- Papa John's International, based
WASHINGTON, May 2, 2014 /PRNewswire-USNewswire/ -- William A.
GULF SHORES, Ala., April 29, 2014 /PRNewswire/ -- If successful, Neuralgene's (http://www.neuralgene.com) PRCN-323 treatment
Forum Uniquely Brings Together Leading Family Offices and Their Foundations Seeking Impact Investment, Grant-Giving, and Philanthropy Opportunities within Health and Life Sciences New
Nationwide fundraising campaign to raise money for ALS research WASHINGTON, April 25, 2014 /PRNewswire-USNewswire/ -- Seventy-five years ago, on July 4, 1939, Lou Gehrig delivered
An ingredient found in Silly Putty could help scientists more efficiently turn human embryonic stem cells into fully functional specialized cells, according to research published online Sunday in the journal Nature Materials.
Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.